approval

Amgen's anti-osteoporosis drug, Prolia wins FDA approval Wed, 02/06/2010 - 17:48 by Neka Sehgal Amgen received approval from the U.S. Food and Drug Administration (FDA) for marketing the drug, Prolia, it has developed to treat and prevent bone loss in postmenopausal women who are at increased risk of fractures. Comments Read more	Google says no to Windows Tue, 01/06/2010 - 12:32 by Anupreet Kaur Internet search giant, Google, has banned the use of Microsoft's Windows operating system (OS) for internal use at its office, as reported by the Financial Times. Google took this decision after the Chinese hacking incident. Comments Read more	FDA clears use of rotavirus vaccine for infants Sat, 15/05/2010 - 15:05 by Neka Sehgal The popular baby vaccine, Rotravix, for preventing rotavirus has been deemed safe with no dangerous side effects by the US Food and Drug Administration (FDA) and doctors have been urged to resume administrating it as part of a regular vaccination schedule. Comments Read more
FDA approves new drug to treat Gaucher Sun, 28/02/2010 - 17:13 by Neka Sehgal Due to the short supply of Cerezyme, the only approved drug for the rare genetic disorder Gaucher, the U.S. Food and Drug Administration (FDA) gave the nod to a new drug Velaglucerase Alfa for injection, (trade name VPRIV), manufactured by Shire Human Genetic Therapies Inc. for pediatric and adult treatment. Comments Read more	Coherent, Inc.: Warming Up or Cooling Off? Fri, 12/02/2010 - 15:16 by Motley Fool Together, we are all trying to build our fortune by finding well-run companies at bargain-basement prices. But it takes work -- scouring company earnings reports, scrutinizing key data, and assessing the competition. Comments Read more	FDA clears anti-cholesterol pill Crestor Tue, 09/02/2010 - 20:08 by Neka Sehgal Washington, February 9 -- AstraZeneca (LSE: AZN) has got the green signal by federal regulators to market its anti-cholesterol pill Crestor. Comments Read more
FDA approves Stelara for psoriasis treatment Sat, 26/09/2009 - 12:48 by Neka Sehgal Rockville, MD, September 25 -- Johnson & Johnson's (NYSE:JNJ) Centocor Ortho Biotech unit announced Friday that the U.S. Food and Drug Administration (FDA) has approved the drug Stelara as treatment for adults with moderate to severe psoriasis. Comments Read more	FDA approves new drug for type 2 diabetes Sat, 01/08/2009 - 14:37 by Neka Sehgal New York, July 31: Bristol-Myers Squibb (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) issued an approval on its new closely watched type 2 diabetes drug ONGLYZA™ (saxagliptin). Comments Read more	FDA delays approval of Botox to treat muscle spasticity Wed, 27/05/2009 - 16:51 by Neka Sehgal Irvine, California, May 27: Allergan Inc. (NYSE:AGN) has been asked to furnish more information to the U.S. health regulators to sell Botox for the treatment of muscle rigidity and spasticity in people who have suffered strokes. Comments Read more